BHVN — Biohaven Pharmaceutical Holding Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge CapMomentum Trap
- $10.56bn
- $11.34bn
- $462.51m
Refinitiv Newscasts - U.S. Day Ahead: Bullish employment numbers raise stakes for July U.S. consumer price report
NewsRefinitiv Newscasts - Pfizer spends billions on another takeover
NewsBiohaven Pharmaceutical Holding Company Ltd reports results for the quarter ended in June - Earnings Summary
NewsBRIEF-Biohaven Pharmaceutical Reports Q2 Loss Per Share $6.21
NewsINVESTIGATION ALERT: Halper Sadeh LLP Investigates HMTV, BHVN, CMAX, VMW
NewsThe M&A Class Action Firm Continues Investigating the Merger
NewsBRIEF-Biohaven Enrolls First Patient In Phase 3 Trial Of Taldefgrobep Alfa In Spinal Muscle Atrophy
NewsBRIEF-Biohaven Says UK Competition & Markets Authority Confirmed That No Further Information Required On Deal With Pfizer
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">BHVN.N</Origin> 139163.0 SHARES ON BUY SIDE
NewsSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, HMTV, SIMO, SREV
NewsLifshitz Law PLLC Announces Investigation of EMCF, FSI, BHVN, and RTLR
NewsBUZZ-FTC's tough rhetoric on pharma M&A in line with expectations - Jefferies
NewsINVESTIGATION ALERT: Halper Sadeh LLP Investigates MUDS, EMCF, FSI, BHVN
NewsLifshitz Law PLLC Announces Investigation of EMCF, FSI, BHVN, and RTLR
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">BHVN.N</Origin> 75172.0 SHARES ON SELL SIDE
NewsBRIEF-Biohaven Underscores Depth Of Migraine Portfolio With Data From Nurtec Odt Long-Term Open Label Study And Phase 3 Zavegepant Trial
NewsINVESTIGATION ALERT: Halper Sadeh LLP Investigates BHVN, EMCF, HR, FSI
NewsBUZZ-Biohaven set for best monthly gain on Pfizer's buyout deal
NewsLifshitz Law PLLC Announces Investigation of EMCF, FSI, BHVN, and RTLR
News